Singapore - inglese - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - alanine; arginine; fish oil, rich in omega -3 acids; glucose monohydrate; glycine; histidine; isoleucine; leucine; lysine acetate; methionine; olive oil, refined; phenylalanine; proline; serine; soya bean oil, refined; taurine; threonine; triglycerides, medium chain; tryptophan; tyrosine; valine - injection, emulsion - 14.0g/1000ml - alanine 14.0g/1000ml; arginine 12.0g /1000ml; fish oil, rich in omega -3 acids 30g /1000ml; glucose monohydrate 462g /1000ml; glycine 11.0g /1000ml; histidine 3.0g /1000ml; isoleucine 5.0g /1000ml; leucine 7.4g /1000ml; lysine acetate 9.3g /1000ml; methionine 4.3g /1000ml; olive oil, refined 50g /1000ml; phenylalanine 5.1g /1000ml; proline 11.2g /1000ml; serine 6.5g /1000ml; soya bean oil, refined 60.0g /1000ml; taurine 1.0g /1000ml; threonine 4.4g /1000ml; triglycerides, medium chain 60g /1000ml; tryptophan 2.0g/1000ml; tyrosine 0.4g /1000ml; valine 6.2g /1000ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

lloyds pharmacy ltd - chlorhexidine gluconate - mouthwash - 2mg/1ml

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

numark ltd - chlorhexidine gluconate - mouthwash - 2mg/1ml

Australia - inglese - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: sodium hydroxide; soya oil; disodium edetate; glycerol; water for injections; egg lecithin - diprivan is a short-acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and in children aged three years and older. diprivan has no analgesic properties. although the safety and efficacy of diprivan in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures. indications as at 4 november 2004: induction of general anaesthesia in children and adults. diprivan is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults. diprivan is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. diprivan may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. diprivan has no analgesic properties. sedation during intensive care in adults. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: glycerol; disodium edetate; sodium hydroxide; egg lecithin; soya oil; water for injections - diprivan is a short-acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and in children aged three years and older. diprivan has no analgesic properties. although the safety and efficacy of diprivan in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures. indications as at 4 november 2004: induction of general anaesthesia in children and adults. diprivan is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults. diprivan is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. diprivan may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. diprivan has no analgesic properties. sedation during intensive care in adults. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: egg lecithin; sodium hydroxide; disodium edetate; glycerol; water for injections; soya oil - diprivan is a short-acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and in children aged three years and older. diprivan has no analgesic properties. although the safety and efficacy of diprivan in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures. indications as at 4 november 2004: induction of general anaesthesia in children and adults. diprivan is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults. diprivan is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. diprivan may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. diprivan has no analgesic properties. sedation during intensive care in adults. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: glycerol; soya oil; disodium edetate; egg lecithin; sodium hydroxide; water for injections - diprivan is a short-acting intravenous anaesthetic agent suitable for induction and maintenance of general anaethesia in adults and in children aged three years and older. diprivan has no analgesic properties. although the safety and efficacy of diprivan in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures. indications as at 4 november 2004: induction of general anaesthesia in children and adults. diprivan is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults. diprivan is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. diprivan may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. diprivan has no analgesic properties. sedation during intensive care in adults. diprivan may also be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults. diprivan may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Armenia - inglese - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pharmacare premium limited - capecitabine - tablets film-coated - 500mg

Malta - inglese - Malta Medicines Authority

pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - film-coated tablet - capecitabine 150 mg - antineoplastic agents

Malta - inglese - Malta Medicines Authority

pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - film-coated tablet - capecitabine 500 mg - antineoplastic agents